Prescription Drugs Market Research Reports & Industry Analysis
The prescription drugs industry is a key cornerstone of healthcare, delivering vital medications that improve and save lives. As this industry continues to evolve, understanding its nuances can be an ongoing challenge. MarketResearch.com provides hundreds of authoritative prescription drugs market research reports to help stakeholders understand the shifting market landscape and devise effective business strategies.
The Latest Prescription Drugs Market Analysis
- We provide data-packed reports on a wide range of product types, therapeutic areas, regions, and companies.
- Our research includes in-depth analyses of prescription drug market size, growth forecasts, and drivers and challenges.
- In addition, we cover the rise of personalized medicine and gene therapies, as well as regulatory issues and pricing models.
Your Dedicated Research Partner
As the prescription drugs industry shifts and changes, MarketResearch.com equips you with the tools to thrive. Trusted for decades as a reliable research partner, our clients include top pharmaceutical companies, investment banks, and universities. Whether you are exploring new markets or seeking to futureproof your business, our prescription drugs industry research reports offer a wealth of knowledge to inform your strategy. Get started by exploring our vast selection of reports on the prescription drugs industry today.
Prescription Drugs Industry Research & Market Reports
-
Benzodiazepine Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Alprazolam, Diazepam, Lorazepam, Clonazepam, and Others); By Dosage Form; By Time of Action, By Application, By Region; Segment Forecast, 2024- 2032
... benzodiazepine drugs market size is expected to reach USD 4,201.27 million by 2032, according to a new study by Polaris Market Research. The report “Benzodiazepine Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug ... Read More
-
Psychedelic Drugs Global Market Report 2024
... addiction; Post- Traumatic Stress Disorder; Narcolepsy; Panic Disorders5) By Distribution Channel: Hospitals Pharmacy; Retail Pharmacy; Online PharmacyCovering: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Novartis International AG Psychedelic Drugs Global Market ... Read More
-
Pharmacies and Drug Stores Global Market Report 2024
... Regulatory Pharmacy; Home Care Pharmacy 3) By Product Type: Skin Care; Cold and Flu; Dental; Weight Loss; VitaminsCovering: CVS Health Corporation; McKesson Corporation; AmerisourceBergen Corporation; Cardinal Health Inc.; Walgreens Boots Alliance Inc. Pharmacies and Drug ... Read More
-
Medication Management System Global Market Report 2024
... By End Users: Pharmacies; HospitalsCovering: McKesson Corporation; Optum Inc.; Cardinal Health Inc.; Siemens Healthcare Private Limited; Becton Dickinson and Company Medication Management System Global Market Report 2024 from The Business Research Company provides strategists, marketers ... Read More
-
Alzheimer’s Disease Treatment Global Market Report 2024
... AntagonistsCovering: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Bayer AG; Novartis AG Alzheimer’s Disease Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information ... Read More
-
Gout (Chronic Refractory)
... Every MarketVue® includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable ... Read More
-
Active Pharmaceutical Ingredient (API) Market in India 2024-2028
... period. The report on the active pharmaceutical ingredient (API) market in India provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The ... Read More
-
Global Antibiotic Resistance Market, By Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Others), By Disease (cUTI (Complicated Urinary Tract Infections), CDI (Clostridioides difficile Infection), ABSSSI (Acute bacterial skin and skin structure infections), HABP (Hospital-acquired bacterial pneumonia), CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), Others (BSI (Bloodstream infection), etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
... CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), Others (BSI (Bloodstream infection), etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The ... Read More
-
Pharma Wholesale and Distribution Market Report 2024-2034
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increasing Government Initiatives for Pharmaceutical Products ... Read More
-
Veterinary Pharmaceuticals Global Market Report 2024
... Recombinant Vaccines Vaccines 4) By Route Of Administration: Oral; Parenteral; Topical 5) By End User: Veterinary Hospitals; Veterinary Clinics; Pharmacies And Drug Stores Covering: Zoetis Inc.; Merck & Co., Inc.; Boehringer Ingelheim International Gmb; Elanco ... Read More
-
Pharmaceutical Drugs Global Market Report 2024
... Respiratory Disease Drugs; Vaccine And Therapeutic Nutrients; Minerals 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores 3) By Drug Classification: Branded Drugs; Generic Drugs 4) By Mode Of Purchase: Over-The-Counter (OTC) Drugs; Prescription-Based ... Read More
-
Osteoarthritis Drugs Market (Drug Class: Corticosteroids, NSAIDs & Others, and Viscosupplementation Agents; and Route of Administration: Oral, Parenteral, and Topical) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Scope of Report TMR’s report on the global osteoarthritis drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the ... Read More
-
UK & Australia Dry Mouth Relief Market Research Report Forecast to 2032
... but rather a complication of several conditions, such as smoking, mouth bleeding, radiation damage to the head and neck, and adverse effects of specific medications. There are a variety of ways to treat a dry ... Read More
-
Global Olanzapine Market Size study & Forecast, by Application (Schizophrenia, Bipolar Disorder, Others), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Drug stores and Retail Pharmacies, Online Providers) and Regional Analysis, 2023-2030
... Global Olanzapine Market is valued at approximately USD 1.84 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 2.3% during the forecast period 2023-2030. Olanzapine is a medication ... Read More
-
Gynecology Drugs Global Market Report 2024
... Covering: Merck & Co. Inc.; AbbVie; Hoffmann-La Roche Ltd.; GlaxoSmithKline Plc; Pfizer Inc. Gynecology Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they ... Read More
-
Pneumonia Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented By Infection Type (Hospital-acquired Pneumonia [HAP], Community-acquired Pneumonia [CAP], Ventilator-associated Pneumonia [VAP]), By Type (Drugs, Preventive Vaccines, Oxygen Therapy), By Drug Class (Antibacterial Drugs, Antiviral Drugs, Antifungal Drugs), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Others) Region and Competition
... Class (Antibacterial Drugs, Antiviral Drugs, Antifungal Drugs), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Others) Region and Competition Global Pneumonia Therapeutics Market was valued at USD 2.21 billion in 2023 and is anticipated ... Read More
-
Finland Pharmaceutical - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... Medicines Agency, data updated in 2022, the COVID-19 pandemic in Finland did not significantly impacted medication availability. To avoid complications even if the situation persists, Finnish healthcare and pharmaceutical operators collaborated closely to prevent shortages. ... Read More
-
Epilepsy Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... impacted the market's growth as several neurology activities, such as medical training and research, were disrupted due to the pandemic. For instance, an article published in the Journal of the International League Against Epilepsy in ... Read More
-
Medication Management System - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029
... USD 5.29 billion by 2029, growing at a CAGR of 11.10% during the forecast period (2024-2029). The COVID-19 pandemic has severely affected the healthcare sector. Several chronic and non-urgent surgeries and treatments were postponed, with ... Read More
-
Vietnam Diabetes Care Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... to reach USD 249.97 million by 2029, growing at a CAGR of 3.70% during the forecast period (2024-2029). Vietnam has effectively stopped transmission of the COVID-19 outbreak since the outset, with no deaths for months. ... Read More
-
Egypt Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... USD 480.70 million by 2029, growing at a CAGR of 3% during the forecast period (2024-2029). The market is estimated to reach a value of more than USD 730 million by 2027. The COVID-19 pandemic ... Read More
-
South Korea Insulin Drugs And Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... of 1.5% and reach a value of about USD 795 million over the forecast period. One of the most significant risk factors for severe COVID-19 was diabetes mellitus. This risk is believed to be influenced ... Read More
-
Endocrinology Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... impacted the endocrinology drugs market since many research studies demonstrated that people with thyroid disorders and diabetes are more prone to COVID-19 infection, creating a significant demand for the appropriate use of various endocrine drugs. ... Read More
-
Global Multiple Sclerosis (MS) Drugs Market Growth 2024-2030
... downstream market, the Multiple Sclerosis (MS) Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Epilepsy Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First-Generation Drugs, Second-Generation Drugs, and Third-Generation Drugs), Age Group (Adults and Children), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... and Others), Treatment Type (First-Generation Drugs, Second-Generation Drugs, and Third-Generation Drugs), Age Group (Adults and Children), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, ... Read More